NAMS Recommendations for Clinical Care of Midlife Women Working Group
Disclosures
NAMS is committed to ensuring balance, independence, and objectivity in all its educational activities. All those involved in the development of Recommendations for Clinical Care of Midlife Women were required to disclose financial relationships they or their spouse/partner have had during the last 12 months with a commercial interest whose products or services are discussed. Disclosures are noted in parentheses after each contributor.
Editorial Panel
Jan L Shifren, MD, NCMP, Editor-in-Chief, Harvard Medical School, Boston, MA (none); Margery LS Gass, MD, NCMP, Editor, Case Western Reserve University School of Medicine, Cleveland, OH (none); Risa Kagan, MD, FACOG, CCD, NCMP, University of California San Francisco, Berkeley, CA (Consultant/Advisory Board: Depomed, Merck, Noven, Novo Nordisk, Pfizer, Shionogi; Grant/Research Support: Therapeutics MD; Speakers Bureau: Noven, Novo Nordisk, Pfizer, Shionogi; Legal Consulting: Actavis, Merck); Andrew M Kaunitz, MD, FACOG, NCMP, University of Florida College of Medicine, Jacksonville, Jacksonville, FL (Consultant/Advisory Board: Actavis, Bayer, Merck, Teva; Grant/Research Support: Bayer, Endoceutics, Medical Diagnostic Laboratories, Noven, Teva, Trimel; Royalties/Patents: UpToDate); James H Liu, MD, Case Western Reserve University School of Medicine, Cleveland, OH (Consultant/Advisory Board or Honoraria: Nora, Noven, Ferring, University of California San Francisco, Decile Ten, Huntworth Health North America, National Institutes of Health); JoAnn E Manson, MD, DrPH, NCMP, Harvard Medical School, Boston, MA (none); JoAnn V Pinkerton, MD, NCMP, University of Virginia Health Sciences Center, Charlottesville, VA (Consultant/Advisory Board: Pfizer, Shionogi, Noven, Novo Nordisk; Grant/Research Support: Therapeutics, Endoceutics); Peter F Schnatz, DO, FACOG, FACP, NCMP, Reading Hospital, Reading, PA (Board of Directors/Trustees: FaithCare); Cynthia A Stuenkel, MD, NCMP, University of California San Diego, La Jolla, CA (none).
Contributors
Sherihan H Allam, MD, MSc, Cleveland Clinic, Cleveland, OH (none); Rebecca H Allen, MD, MPH, Warren Alpert Medical School of Brown University, Providence, RI (none); Gloria A Bachmann, MD, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (Consultant/Advisory Board: TEVA; Royalties/Patents and Authorship: UpToDate); C Noel Bairey Merz, MD, FACC, FAHA, Cedars-Sinai Medical Center, Los Angeles, CA (Consultant/Advisory Board: Gilead, Japanese Circulation Society; Grant/Research Support: Cardiac Research Institute, University of New Mexico, National Institutes of Health Special Emphasis Panel; Lectures: Mayo Foundation, Bryn Mawr Hospital, Practice Point Communications, Allegheny General Hospital, Duke University, Vox Media, Emory University, Preventive Cardiovascular Nurses Association, Kaiser Permanente, Garden State American Heart Association; Honorarium: University of California, San Francisco); Wilma F Bergfeld, MD, FAAD, Cleveland Clinic, Cleveland, OH (none); Joel A Block, MD, Rush University Medical Center, Chicago, IL (Royalties/Patents: GlaxoSmithKline, Daichii-Sankyo, Agios; Chair: Data and Safety Monitoring Board; Royalties: PLx Pharma); Thomas B Clarkson, DVM, Wake Forest University School of Medicine, WinstonSalem, NC (none); Janine Austin Clayton, MD, National Institutes of Health, Bethesda, MD (none); Carrie Cwiak, MD, MPH, Emory University School of Medicine, Atlanta, GA (Faculty Trainer: Merck; Grant/Research Support: Medicines 360; Royalties/Patents: Springer); Susan R Davis, MBBS, FRACP, PhD, Monash University, Melbourne, Australia (Consultant/Advisory Board: Trimel; Grant/Research Support: Lawley); Dima Diab, MD, University of Cincinnati College of Medicine, Cincinnati, OH (none); Robert R Freedman, PhD, Wayne State University School of Medicine, Detroit, MI (none); George I Gorodeski, MD, MSc, PhD, NCMP, Case Western Reserve University, Cleveland, OH (none); Victor W Henderson, MD, MS, NCMP, Stanford University, Stanford, CA (none); Catherine A Henry, MD, FACP, Cleveland Clinic, Cleveland, OH (none); Andrew G Herzog, MD, MSc, Harvard Medical School, Boston, MA (none); David A Hutchins, MD, NCMP, University of Arkansas for Medical Sciences, Little Rock, AR (none); Michelle Inkster, MD, PhD, Cleveland Clinic, Cleveland, OH (none); Hadine Joffe, MD, MSc, Harvard Medical School, Boston, MA (Grant/Research Support: Cephalon, Noven, Sunovion); Risa Kagan, MD, FACOG, CCD, NCMP, University of California San Francisco, Berkeley, CA (Consultant/Advisory Board: Depomed, Merck, Noven, Novo Nordisk, Pfizer, Shionogi; Grant/Research Support: Therapeutics MD; Speakers Bureau: Noven, Novo Nordisk, Pfizer, Shionogi; Legal Consulting: Actavis, Merck); Andrew M Kaunitz, MD, NCMP, University of Florida College of Medicine-Jacksonville, Jacksonville, FL (Consultant/Advisory Board: Actavis, Bayer, Merck, Teva; Grant/Research Support: Bayer, Endoceutics, Medical Diagnostic Laboratories, Noven, Teva, Trimel; Royalties/Patents: UpToDate); Fredi Kronenberg, PhD, Stanford University, Stanford, CA (none); James H Liu, MD, Case Western Reserve University School of Medicine, Cleveland, OH (Consultant/Advisory Board or Honoraria: Nora, Noven, Ferring, University of California San Francisco, Decile Ten, Huntworth Health North America, National Institutes of Health); Tieraona Low Dog, MD, University of Arizona, Tucson, AZ (Consultant/Advisory Board: Pharmaca, Weil Lifestyle); JoAnn E Manson, MD, DrPH, NCMP, Harvard Medical School, Boston, MA (none); Susan C Modesitt, MD, FACOG, FACS, University of Virginia Health Sciences Center, Charlottesville, VA (none); Jeri W Nieves, PhD, Helen Hayes Hospital and Columbia University, New York, NY (none); Joan Otomo-Corgel, DDS, MPH, FACD, University of California, Los Angeles School of Dentistry, Los Angeles, CA (none); Diane T Pace, PhD, FNP-BC, NCMP, FAANP, University of Memphis Loewenberg School of Nursing, Memphis, TN (Consultant/Advisory Board: Hologic, Pfizer); Bruce Patsner, MD, JD, Genzyme, Cambridge, MA (none); Rebecca B Perkins, MD, MSc, Boston University School of Medicine, Boston, MA (none); Nancy A Phillips, MD, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ (none); JoAnn V Pinkerton, MD, NCMP, University of Virginia Health Sciences Center, Charlottesville, VA (Consultant/Advisory Board: Pfizer, Shionogi, Noven, Novo Nordisk; Grant/Research Support: Therapeutics, Endoceutics); Brenda Powell, MD, ABIHM, Cleveland Clinic, Cleveland, OH (none); Laurel Rice, MD, University of Wisconsin School of Medicine and Public Health, Madison, WI (none); Sheila Mary Rice Dane, MD, FACP, NCMP, Case Western Reserve University, Cleveland, OH (none); Gloria Richard-Davis, MD, FACOG, University of Arkansas Medical Sciences, Little Rock, AR (Consultant/Advisory Board: Pfizer); Marcie K Richardson, MD, NCMP, Harvard Medical School, Boston, MA (none); Nanette Santoro, MD, University of Colorado School of Medicine, Aurora, CO (Grant/Research Support: Bayer; Stock/Ownership: Menogenix); Jan L Shifren, MD, NCMP, Harvard MedicalSchool, Boston, MA (none); Chrisandra Shufelt, MD, MS, FACP, NCMP, Cedars-Sinai Medical Center, Los Angeles, CA (none); Andrea Sikon, MD, FACP, NCMP, Case Western Reserve University, Cleveland, OH (none); Sahar M Stephens, MD, University of Colorado School of Medicine, Aurora, CO (none); Cynthia A Stuenkel, MD, NCMP, University of California San Diego, La Jolla, CA (none); Eliza L Sutton, MD, FACP, University of Washington, Seattle, WA (none); Holly L Thacker, MD, FACP, CCD, NCMP, Case Western Reserve University, Cleveland, OH (Consultant/Advisory Board: Noven, Pfizer, Myriad; Speakers Bureau: Novo Nordisk, Amgen, Shionogi, Novartis); Wulf H Utian, MD, PhD, DSc(Med), Case Western Reserve University School of Medicine, Cleveland, OH (Consultant/Advisory Board: Metagenics, Pharmavite, Primus Pharmaceuticals, SenoSENSE); Victor G Vogel,MD, MHS, Geisinger Health System, Danville, PA (none); L Elaine Waetjen, MD, University of California Davis School of Medicine, Sacramento, CA (none); Nelson Watts, MD, Mercy Health System, Cincinnati, OH (Consultant/Advisory Board: AbbVie, Amarin, Amgen, Bristol-Meyers Squibb, Corcept, Endo, Imagepace, Janssen, Lilly, Merck, Novartis, Noven, Pfizer/Wyeth, Radius, Sanofi-Aventis; Grant/Research Support: Merck, NPS; Stock/Ownership/Royalties: OsteoDynamics; Honoraria: Amgen, Merck); Melissa Wellons, MD, MHS, Vanderbilt University Medical Center, Nashville, TN (none); Barbara Wilson, MD, University of Virginia Health System, Charlottesville, VA (none); Nancy Fugate Woods, PhD, RN, FAAN, University of Washington School of Nursing, Seattle, WA (none); Tonita E Wroolie, PhD, Stanford University School of Medicine, Stanford, CA (none); Jeanne Young, MD, University of Virginia Health System, Charlottesville, VA (none); Nese Yuksel, BScPharm, PharmD, FCSHP, NCMP, University of Alberta, Edmonton, AB, Canada (none).
2013-2014 NAMS Board of Trustees
Margery LS Gass, MD, NCMP (Executive Director), Case Western Reserve University School of Medicine, Cleveland, OH (none); Jan L Shifren, MD, NCMP (President), Harvard Medical School, Boston, MA (none); Pauline M Maki, PhD (President Elect), University of Illinois at Chicago, Chicago, IL (Consultant: Pfizer; Speaking Honorarium: Abbott); Diane T Pace, PhD, FNP-BC, FAANP, NCMP (Immediate Past President), University of Memphis Loewenberg School of Nursing, Memphis, TN (Consultant/Advisory Board: Hologic, Pfizer); Peter F Schnatz, DO, FACOG, FACP, NCMP (Treasurer), Reading Hospital, Reading, PA (Board of Directors/ Trustees: FaithCare); Andrew M Kaunitz, MD, FACOG, NCMP (Secretary), University of Florida College of Medicine-Jacksonville, Jacksonville, FL (Consultant/Advisory Board: Actavis, Bayer, Merck, Teva; Grant/Research Support: Bayer, Endoceutics, Medical Diagnostic Laboratories, Noven, Teva, Trimel; Royalties/Patents: UpToDate); Howard N Hodis, MD, University of Southern California, Los Angeles, CA (none); Sheryl A Kingsberg, PhD, Case Western Reserve University School of Medicine, Cleveland, OH (Consultant/Advisory Board: Apricus, Emotional Brain, Novo Nordisk, Palatin, Pfizer, Shionogi, Sprout, SST, Teva, Trimel Biopharm, Viveve); Lynnette Leidy Sievert, BSN, PhD, University of Massachusetts, Amherst, MA (none); James H Liu, MD, Case Western Reserve University School of Medicine, Cleveland, OH (Consultant/Advisory Board or Honoraria: Nora, Noven, Ferring, University of California San Francisco, Decile Ten, Huntworth Health North America, National Institutes of Health); JoAnn E Manson, MD, DrPH, NCMP, Harvard Medical School, Boston, MA (none); Gloria Richard-Davis, MD, FACOG, University of Arkansas Medical Sciences, Little Rock, AR (Consultant/ Advisory Board: Pfizer); Marla Shapiro, MDCM, CCFP, MHSc, FRCP(C), FCFP, NCMP, University of Toronto, Toronto, ON (Board of Directors/Trustees: Women's College Hospital, Research Canada, Dairy Farmers of Canada, Canadian Foundation for Women and Health; Employment: Consultant, CTV Canada AM, CTV National News, CTV NewsChannel, Parents Canada; Consultant/Advisory Board: Amgen, AstraZeneca, Merck, Novartis, Pfizer, Actavis; Speaker's Bureau: Amgen, Merck, Novartis, Novo Nordisk, Pfizer; Website Writer: CTV.ca, healthandbone.ca); Isaac Schiff, MD (Ex Officio), Harvard Medical School, Boston, MA (none); Wulf H Utian, MD, PhD, DSc(Med) (Ex Officio), Case Western Reserve University School of Medicine, Cleveland, OH (Consultant/Advisory Board: Metagenics, Pharmavite, Primus Pharmaceuticals, SenoSENSE).